BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29715148)

  • 1. A Score to Identify Patients with Brain Metastases from Colorectal Cancer Who May Benefit from Whole-brain Radiotherapy in Addition to Stereotactic Radiosurgery/Radiotherapy.
    Rades D; Dziggel L; Blanck O; Gebauer N; Bartscht T; Schild SE
    Anticancer Res; 2018 May; 38(5):3111-3114. PubMed ID: 29715148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the Risk of Developing New Cerebral Lesions After Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy for Brain Metastases from Renal Cell Carcinoma.
    Rades D; Dziggel L; Blanck O; Gebauer N; Bartscht T; Schild SE
    Anticancer Res; 2018 May; 38(5):2973-2976. PubMed ID: 29715126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A New Predictive Tool for Optimization of the Treatment of Brain Metastases from Colorectal Cancer After Stereotactic Radiosurgery.
    Rades D; Dahlke M; Gebauer N; Bartscht T; Hornung D; Trang NT; Phuong PC; Khoa MT; Gliemroth J
    Anticancer Res; 2015 Oct; 35(10):5515-8. PubMed ID: 26408718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying melanoma patients with 1-3 brain metastases who may benefit from whole-brain irradiation in addition to radiosurgery.
    Huttenlocher S; Sehmisch L; Schild SE; Blank O; Hornung D; Rades D
    Anticancer Res; 2014 Oct; 34(10):5589-92. PubMed ID: 25275060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the Risk of New Cerebral Lesions After Stereotactic Radiosurgery (SRS) for Brain Metastases from Breast Cancer.
    Dziggel L; Dahlke M; Janssen S; Hornung D; Blanck O; Khoa MT; Schild SE; Rades D
    Anticancer Res; 2015 Dec; 35(12):6793-7. PubMed ID: 26637898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do patients with very few brain metastases from breast cancer benefit from whole-brain radiotherapy in addition to radiosurgery?
    Rades D; Huttenlocher S; Hornung D; Blanck O; Schild SE; Fischer D
    Radiat Oncol; 2014 Dec; 9():267. PubMed ID: 25472758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
    Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
    J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stereotactic radiosurgery and radiotherapy for brain metastases].
    Tanguy R; Métellus P; Mornex F; Mazeron JJ
    Bull Cancer; 2013 Jan; 100(1):75-81. PubMed ID: 23376580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of five or more brain metastases with stereotactic radiosurgery.
    Hunter GK; Suh JH; Reuther AM; Vogelbaum MA; Barnett GH; Angelov L; Weil RJ; Neyman G; Chao ST
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1394-8. PubMed ID: 22209150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A matched-pair study comparing whole-brain irradiation alone to radiosurgery or fractionated stereotactic radiotherapy alone in patients irradiated for up to three brain metastases.
    Rades D; Janssen S; Dziggel L; Blanck O; Bajrovic A; Veninga T; Schild SE
    BMC Cancer; 2017 Jan; 17(1):30. PubMed ID: 28061768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypofractionated stereotactic radiotherapy in combination with whole brain radiotherapy for brain metastases.
    Giubilei C; Ingrosso G; D'Andrea M; Benassi M; Santoni R
    J Neurooncol; 2009 Jan; 91(2):207-12. PubMed ID: 18807149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Survival Score for Patients Receiving Stereotactic Radiosurgery Alone for Brain Metastases from Breast Cancer.
    Rades D; Dziggel L; Janssen S; Blanck O; Hornung D; Schild SE
    Anticancer Res; 2016 Mar; 36(3):1073-6. PubMed ID: 26977000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of patients with ≥4 brain metastases using stereotactic radiosurgery boost after whole brain irradiation.
    Dincoglan F; Sager O; Gamsiz H; Uysal B; Demiral S; Oysul K; Sirin S; Caglan A; Beyzadeoglu M
    Tumori; 2014; 100(3):302-6. PubMed ID: 25076242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosurgery for brain metastases from primary lung carcinoma.
    Hoffman R; Sneed PK; McDermott MW; Chang S; Lamborn KR; Park E; Wara WM; Larson DA
    Cancer J; 2001; 7(2):121-31. PubMed ID: 11324765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidisciplinary treatment of brain metastases derived from colorectal cancer incorporating stereotactic radiosurgery: analysis of 78 patients.
    Fokas E; Henzel M; Hamm K; Surber G; Kleinert G; Engenhart-Cabillic R
    Clin Colorectal Cancer; 2011 Jun; 10(2):121-5. PubMed ID: 21859565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Karnofsky performance status and lactate dehydrogenase predict the benefit of palliative whole-brain irradiation in patients with advanced intra- and extracranial metastases from malignant melanoma.
    Partl R; Richtig E; Avian A; Berghold A; Kapp KS
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):662-6. PubMed ID: 22901382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects.
    Niibe Y; Nishimura T; Inoue T; Karasawa K; Shioyama Y; Jingu K; Shirato H
    BMC Cancer; 2016 Aug; 16(1):659. PubMed ID: 27542716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiosurgery alone versus radiosurgery plus whole-brain irradiation for very few cerebral metastases from lung cancer.
    Rades D; Huttenlocher S; Hornung D; Blanck O; Schild SE
    BMC Cancer; 2014 Dec; 14():931. PubMed ID: 25496194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer metastatic to the brain: analysis of prognostic factors and impact of KRAS mutations on presentation and outcome.
    Nieder C; Hintz M; Grosu AL
    Clin Transl Oncol; 2016 Jan; 18(1):88-92. PubMed ID: 26260912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.